You have free access to this content

British Journal of Clinical Pharmacology

Cover image for Vol. 67 Issue 5

May 2009

Volume 67, Issue 5

Pages 485–587

  1. Editors' view

    1. Top of page
    2. Editors' view
    3. Commentaries
    4. Pharmacokinetic dynamic relationships
    5. Drug interactions
    6. Therapeutics
    7. Drug safety
    8. Pharmacoepidemiology
    9. Short report
    10. Letters to the editors
    11. Mandarin translations section
    1. You have free access to this content
  2. Commentaries

    1. Top of page
    2. Editors' view
    3. Commentaries
    4. Pharmacokinetic dynamic relationships
    5. Drug interactions
    6. Therapeutics
    7. Drug safety
    8. Pharmacoepidemiology
    9. Short report
    10. Letters to the editors
    11. Mandarin translations section
    1. You have free access to this content
    2. You have free access to this content
      Orphan drug development is not taking off (pages 494–502)

      Roberta Joppi, Vittorio Bertele and Silvio Garattini

      Version of Record online: 21 JAN 2009 | DOI: 10.1111/j.1365-2125.2009.03369.x

  3. Pharmacokinetic dynamic relationships

    1. Top of page
    2. Editors' view
    3. Commentaries
    4. Pharmacokinetic dynamic relationships
    5. Drug interactions
    6. Therapeutics
    7. Drug safety
    8. Pharmacoepidemiology
    9. Short report
    10. Letters to the editors
    11. Mandarin translations section
    1. You have free access to this content
    2. You have free access to this content
      Amiodarone concentrations in plasma and fat tissue during chronic treatment and related toxicity (pages 511–519)

      Carmelo Lafuente-Lafuente, Jean-Claude Alvarez, Antoine Leenhardt, Stéphane Mouly, Fabrice Extramiana, Charles Caulin, Christian Funck-Brentano and Jean-François Bergmann

      Version of Record online: 2 FEB 2009 | DOI: 10.1111/j.1365-2125.2009.03381.x

  4. Drug interactions

    1. Top of page
    2. Editors' view
    3. Commentaries
    4. Pharmacokinetic dynamic relationships
    5. Drug interactions
    6. Therapeutics
    7. Drug safety
    8. Pharmacoepidemiology
    9. Short report
    10. Letters to the editors
    11. Mandarin translations section
    1. You have free access to this content
    2. You have free access to this content
    3. You have free access to this content
      Enantioselective disposition of fexofenadine with the P-glycoprotein inhibitor verapamil (pages 535–540)

      Takashi Sakugawa, Masatomo Miura, Nobuo Hokama, Toshio Suzuki, Tomonori Tateishi and Tsukasa Uno

      Version of Record online: 23 FEB 2009 | DOI: 10.1111/j.1365-2125.2009.03396.x

    4. You have free access to this content
  5. Therapeutics

    1. Top of page
    2. Editors' view
    3. Commentaries
    4. Pharmacokinetic dynamic relationships
    5. Drug interactions
    6. Therapeutics
    7. Drug safety
    8. Pharmacoepidemiology
    9. Short report
    10. Letters to the editors
    11. Mandarin translations section
    1. You have free access to this content
      Influence of pharmaceutical care on health outcomes in patients with Type 2 diabetes mellitus (pages 547–557)

      Nadia Rashid Al Mazroui, Mostafa Mohamed Kamal, Naserdeen Mehana Ghabash, Targ Ahmed Yacout, Prashant Laxman Kole and James C. McElnay

      Version of Record online: 11 FEB 2009 | DOI: 10.1111/j.1365-2125.2009.03391.x

  6. Drug safety

    1. Top of page
    2. Editors' view
    3. Commentaries
    4. Pharmacokinetic dynamic relationships
    5. Drug interactions
    6. Therapeutics
    7. Drug safety
    8. Pharmacoepidemiology
    9. Short report
    10. Letters to the editors
    11. Mandarin translations section
    1. You have free access to this content
  7. Pharmacoepidemiology

    1. Top of page
    2. Editors' view
    3. Commentaries
    4. Pharmacokinetic dynamic relationships
    5. Drug interactions
    6. Therapeutics
    7. Drug safety
    8. Pharmacoepidemiology
    9. Short report
    10. Letters to the editors
    11. Mandarin translations section
    1. You have free access to this content
      Determinants of the drug utilization profile in the paediatric population in Italy's Lombardy Region (pages 565–571)

      Antonio Clavenna, Marco Sequi, Angela Bortolotti, Luca Merlino, Ida Fortino and Maurizio Bonati

      Version of Record online: 2 FEB 2009 | DOI: 10.1111/j.1365-2125.2009.03380.x

  8. Short report

    1. Top of page
    2. Editors' view
    3. Commentaries
    4. Pharmacokinetic dynamic relationships
    5. Drug interactions
    6. Therapeutics
    7. Drug safety
    8. Pharmacoepidemiology
    9. Short report
    10. Letters to the editors
    11. Mandarin translations section
    1. You have free access to this content
  9. Letters to the editors

    1. Top of page
    2. Editors' view
    3. Commentaries
    4. Pharmacokinetic dynamic relationships
    5. Drug interactions
    6. Therapeutics
    7. Drug safety
    8. Pharmacoepidemiology
    9. Short report
    10. Letters to the editors
    11. Mandarin translations section
    1. You have free access to this content
      Cetirizine-induced anaphylaxis: a rare adverse drug reaction (pages 577–578)

      Nisha Afonso, Pankaj Shetgaonkar, Amit Dang and Padmanabh V. Rataboli

      Version of Record online: 23 FEB 2009 | DOI: 10.1111/j.1365-2125.2009.03394.x

    2. You have free access to this content
      Acute oxcarbazepine overdose in an autistic boy (pages 579–581)

      Maura Pedrini, Antoni Noguera, Joan Vinent, Mercè Torra and Rafael Jiménez

      Version of Record online: 26 FEB 2009 | DOI: 10.1111/j.1365-2125.2009.03398.x

  10. Mandarin translations section

    1. Top of page
    2. Editors' view
    3. Commentaries
    4. Pharmacokinetic dynamic relationships
    5. Drug interactions
    6. Therapeutics
    7. Drug safety
    8. Pharmacoepidemiology
    9. Short report
    10. Letters to the editors
    11. Mandarin translations section
    1. You have free access to this content

SEARCH

SEARCH BY CITATION